- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nanosphere, Inc. (NASDAQ: NSPH), a nanotechnology-based molecular diagnostics company, today announced that the underwriters of Nanosphere's recent initial public offering of its common stock exercised in full their over-allotment option to purchase an additional 1,050,000 shares of Nanosphere's common stock at $14.00 per share, less underwriting discounts and commissions. The option was granted in connection with Nanosphere's initial public offering of 7,000,000 shares. The closing of the sale of all 8,050,000 shares by Nanosphere to the underwriters occurred earlier today.
Credit Suisse Securities (USA) LLC acted as the sole book-running manager for the offering. Piper Jaffray & Co., Leerink Swann LLC, and Allen & Company LLC acted as co-managers.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on October 31, 2007. This offering is being made solely by means of a prospectus. Copies of the final prospectus relating to this offering may be obtained from Credit Suisse, Prospectus Department, One Madison Avenue, Level 1B, New York, NY 10010 (telephone number: (212) 325-2580).
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System for direct genomic and ultra-sensitive protein detection. This easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL.
For more information, please click here
Schwartz Communications, Inc.
Laura Kempke or Andrea tenBroek, 781-684-0770
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
FEI Company: Strong Growth Prospects Remain May 1st, 2015
Arrowhead to Present at Upcoming Conferences April 28th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Polymeric Nanocarriers Improve Performance of Anticancer Drugs April 30th, 2015
Time Dependant Spectroscopy of Microscopic Samples: CRAIC TimePro™ software is used with CRAIC Technologies microspectrometers to measure the kinetic UV-visible-NIR, Raman and fluorescence spectra of microscopic sample areas May 2nd, 2015